"[T]he rule is conspicuously silent about discrimination on the basis of health status.... The reticence to address 'price-based' discrimination likely stems from insurers historically charging different prices for medications and services. Insurers argue that this pricing structure allows them to encourage the use of more low-cost services and medications. However, this omission even has the potential to undermine the very forms of discrimination that the proposed Section 1557 regulation aims to protect against."  MORE >>